Literature DB >> 28215841

Prognosis of women with apparent stage I endometrial cancer who had supracervical hysterectomy.

Koji Matsuo1, Hiroko Machida2, Tsuyoshi Takiuchi2, Jocelyn Garcia-Sayre2, Annie A Yessaian3, Lynda D Roman3.   

Abstract

OBJECTIVE: To examine characteristics and survival outcomes of women with apparent early-stage endometrial cancer who had a supracervical hysterectomy.
METHODS: The Surveillance, Epidemiology, and End Results Program was used to identify women with presumed stage I endometrial cancer who underwent supracervical hysterectomy between 1983 and 2012. Propensity score matching was performed to adjust background difference between supracervical hysterectomy (n=1,339) and total hysterectomy (n=110,523) cases. Endometrial cancer-specific survival (CSS) was examined by multivariable analysis expressed with adjusted-hazard ratio [HR] and 95% confidence interval [CI].
RESULTS: Supracervical hysterectomy was independently associated with younger age, low-grade disease, and small tumor size on multivariable analysis (all, P<0.001). After propensity score matching, supracervical hysterectomy remained an independent prognostic factor for decreased CSS compared to total hysterectomy (10-year rates, 91.0% versus 94.9%, adjusted-HR 1.72, 95%CI 1.20-2.47, P=0.003). Among women who received postoperative radiotherapy, 10-year CSS rates were similar between supracervical and total hysterectomy cases (84.7% versus 80.3%, P=0.40). Contrary, in the absence of postoperative radiotherapy, women undergoing supracervical hysterectomy had a significantly lower 10-year CSS rate compared to those undergoing total hysterectomy (92.1% versus 97.2%, P<0.001). Moreover, with lack of lymphadenectomy, supracervical hysterectomy was associated with decreased CSS compared to those who had total hysterectomy (91.6% versus 94.3%, P=0.018) but had similar CSS rates with lymphadenectomy (92.7% versus 91.8%, P=0.91).
CONCLUSION: Although rarely performed, supracervical hysterectomy is associated with decreased survival outcome among women with apparent stage I endometrial cancer supporting the importance of avoiding this procedure in women with or at risk of endometrial cancer.
Copyright © 2017 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Endometrial cancer; Radiotherapy; Supracervical hysterectomy; Survival outcome

Mesh:

Year:  2017        PMID: 28215841      PMCID: PMC7523224          DOI: 10.1016/j.ygyno.2017.02.004

Source DB:  PubMed          Journal:  Gynecol Oncol        ISSN: 0090-8258            Impact factor:   5.482


  25 in total

Review 1.  Total and supracervical hysterectomy.

Authors:  Sarah L Cohen; Jon I Einarsson
Journal:  Obstet Gynecol Clin North Am       Date:  2011-12       Impact factor: 2.844

Review 2.  Total versus subtotal hysterectomy for benign gynaecological conditions.

Authors:  A Lethaby; V Ivanova; N P Johnson
Journal:  Cochrane Database Syst Rev       Date:  2006-04-19

3.  The American College of Obstetricians and Gynecologists Committee Opinion no. 631. Endometrial intraepithelial neoplasia.

Authors: 
Journal:  Obstet Gynecol       Date:  2015-05       Impact factor: 7.661

4.  Subtotal hysterectomy in modern gynecology: a decision analysis.

Authors:  J R Scott; H T Sharp; M K Dodson; P A Norton; H R Warner
Journal:  Am J Obstet Gynecol       Date:  1997-06       Impact factor: 8.661

5.  Unanticipated uterine pathologic finding after morcellation during robotic-assisted supracervical hysterectomy and cervicosacropexy for uterine prolapse.

Authors:  Audra Jolyn Hill; Ashley W Carroll; Catherine A Matthews
Journal:  Female Pelvic Med Reconstr Surg       Date:  2014 Mar-Apr       Impact factor: 2.091

6.  Management of uterine malignancy found incidentally after supracervical hysterectomy or uterine morcellation for presumed benign disease.

Authors:  M H Einstein; R R Barakat; D S Chi; Y Sonoda; K M Alektiar; M L Hensley; N R Abu-Rustum
Journal:  Int J Gynecol Cancer       Date:  2007-11-06       Impact factor: 3.437

7.  Randomised controlled trial of total compared with subtotal hysterectomy with one-year follow up results.

Authors:  Helga Gimbel; Vibeke Zobbe; Birthe Margrethe Andersen; Thomas Filtenborg; Christian Gluud; Ann Tabor
Journal:  BJOG       Date:  2003-12       Impact factor: 6.531

8.  High-volume ovarian cancer care: survival impact and disparities in access for advanced-stage disease.

Authors:  Robert E Bristow; Jenny Chang; Argyrios Ziogas; Leslie M Randall; Hoda Anton-Culver
Journal:  Gynecol Oncol       Date:  2013-12-20       Impact factor: 5.482

9.  Laparoscopic supracervical hysterectomy with morcellation: should it stay or should it go?

Authors:  Jubilee Brown; Kristal Taylor; Pedro T Ramirez; Charlotte Sun; Laura L Holman; S Mark Cone; John Irwin; Michael Frumovitz
Journal:  J Minim Invasive Gynecol       Date:  2014-09-19       Impact factor: 4.137

10.  Malignancy rate of 10,731 uteri morcellated during laparoscopic supracervical hysterectomy (LASH).

Authors:  Bernd Bojahr; Rudy Leon De Wilde; Garri Tchartchian
Journal:  Arch Gynecol Obstet       Date:  2015-03-28       Impact factor: 2.344

View more
  1 in total

1.  Trends and outcomes of women with synchronous endometrial and ovarian cancer.

Authors:  Koji Matsuo; Hiroko Machida; Erin A Blake; Laura L Holman; Bobbie J Rimel; Lynda D Roman; Jason D Wright
Journal:  Oncotarget       Date:  2018-06-19
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.